Innovating Works
SOMIT: Leveraging a novel platform technology to develop a first in class immunotherapy for Celiac Disease ALLERO THERAPEUTICS tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Celiac Disease is a debilitating autoimmune disorder that is caused by intolerance to gluten. Although it is the most common genetically-bas...
2018-08-01 - 2019-02-28 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.